bioRxivCell BiologyPreprint
Myofiber / pro-inflammatory macrophage interplay controls muscle damage in mdx mice
M. Saclier, S. Ben Larbi, E. Moulin, R. Mounier, B. Chazaud, G. Juban
Abstract
Duchenne Muscular Dystrophy is a genetic muscle disease characterized by chronic inflammation and fibrosis, which is mediated by a pro-fibrotic macrophage population expressing pro-inflammatory markers. The aim of this study was to characterize cellular events leading to the alteration of macrophage properties, and to modulate macrophage inflammatory status using the gaseous mediator H2S. We first analyzed the relationship between myofibers and macrophages in the mdx mouse model of Duchenne Muscular Dystrophy using coculture experiments. We showed that normal myofibers derived from mdx mice strongly skewed the polarization of resting macrophages towards a pro-inflammatory phenotype. Treatment of mdx mice with NaHS, an H2S donor, reduced the number of pro-inflammatory macrophages in skeletal muscle, which was associated with a decrease in the number of nuclei per fiber, a reduction of myofiber branching and a reduced fibrosis. These results identify an interplay between myofibers and macrophages where dystrophic myofibers contribute to the maintenance of a highly inflammatory environment that skews the macrophage status, which in turn favors myofiber damage, myofiber branching and fibrosis establishment. They also identify H2S donors as a potential therapeutic strategy to improve dystrophic muscle phenotype by modulating macrophage inflammatory status.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selective ablation of Nfix in Macrophages preserves Muscular Dystrophy by inhibiting FAPs-dependent fibrosis
M. Saclier, G. Temponi, … G. Messina·bioRxiv·May 12, 2021
- Single-cell and spatial transcriptomics identify a macrophage population associated with skeletal muscle fibrosis
G. COULIS, D. Jaime, … A. Villalta·bioRxiv·Apr 18, 2023
- Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD
D. A. Mazala, R. Hindupur, … J. K. Jaiswal·bioRxiv·Mar 27, 2023
- In dystrophic mdx hindlimb muscles where fibrosis is limited versican haploinsufficiency transiently improves contractile function without decreasing inflammation
Danielle A. Debruin, Natasha L. McRae, … Nicole Stupka·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Aug 19, 2024
- Benfotiamine reduces pathology and improves muscle function in mdx mice.
Keryn G. Woodman, Chantal A. Coles, … Jason D. White·bioRxiv·Mar 25, 2018
- NOX4 inhibition promotes the remodeling of dystrophic muscle
D. W. Hammers·bioRxiv·Jan 8, 2022